Homepage

News

Amended policy relating to patented indications

Octrooi

08-05-2019 | 13:00

The Medicines Evaluation Board (MEB) will no longer publish the full product information about the active substance of generic ...

The MEB in 2018: A focus on core tasks

Jaarverslag 2018

11-04-2019 | 16:00

'At the MEB life is never boring'. This is how MEB chair Ton de Boer and director Hugo Hurts start their review of 2018. This ...

Change in policy on patient information due to judgement by the European Court of Justice

Octrooi

28-03-2019 | 09:30

The Medicines Evaluation Board (MEB) will no longer publish the full product information about the active substance of generic ...

Science Magazine, 7th edition: Rapid developments in advanced therapies and the vision for Regulatory Science 2025

15-03-2019 | 14:00

The MEB, the Dutch medicines authority, publishes the seventh edition of its Regulatory Science Magazine today. This edition ...

Brexit: Notification by the European Commission/EMA/CMDh and CMDv about Brexit and EU rules for batch control of medicinal products

05-03-2019 | 14:00

On 25 February 2019 the European Commission (EC) published a notice on the European rules for batch control testing of medicinal ...

MEB fee rate change as of January 2019

11-12-2018 | 09:00

The Medicines Evaluation Board (MEB) is increasing the fee rates for authorisation applications, authorisation changes and the ...
More news